-
461
-
462
-
463
Polymeric nanomedicines for the treatment of hepatic diseases
Published 2022-11-01Subjects: Get full text
Article -
464
PIMT regulates hepatic gluconeogenesis in mice
Published 2023-03-01“…The PKA-PIMT-Ep300 signaling module and associated PIMT regulation may serve as a key driver of gluconeogenesis, positioning PIMT as a critical hepatic glucose sensor.…”
Get full text
Article -
465
Hepatic encephalopathy due to cardiac cirrhosis
Published 2023-09-01Subjects: Get full text
Article -
466
Benign Hepatic Neoplasms: An Imaging Review
Published 2023-05-01“…Radiologists should also be acquainted with features of rare hepatic neoplasms like angiomyolipoma, paraganglioma, and inflammatory pseudotumor. …”
Get full text
Article -
467
Etiopathogenesis and Diagnostic Strategies in Autoimmune Hepatitis
Published 2021-08-01Subjects: “…autoimmune hepatitis…”
Get full text
Article -
468
Recent Advances in Hepatitis B Treatment
Published 2021-05-01Subjects: “…hepatitis B…”
Get full text
Article -
469
BLOOD DONOR SCREENING FOR HEPATITIS AND HIV
Published 2007-09-01“…Donors that have any disease such as viral hepatitis, malaria, venereal disease, AIDS are excluded from blood donation2. …”
Get full text
Article -
470
Innovations in Hepatitis C Screening and Treatment
Published 2021-03-01“…New therapies offer hope for a cure to millions of persons living with hepatitis C virus (HCV) infection. HCV elimination is a global goal that will be difficult to achieve using the traditional paradigms of diagnosis and care. …”
Get full text
Article -
471
Betaleukin in therapy of chronic hepatitis C
Published 2014-10-01“…The article presents the problems of modern antiviral therapy of chronic hepatitis C. The effectiveness of combined therapy with pegylated interferon and ribavirin in patients infected with 1st genotype is not more than 50%. …”
Get full text
Article -
472
-
473
EXPERIMENTAL APPROACHES TO IMMUNOPHARMACOTHERAPY FOR TOXIC HEPATITIS
Published 2015-09-01“…Humoral and cellular factors of natural resistance in different blood vessels for experimental CCl4-hepatitis have been studied. Sharp decrease of all factors have been detected with prevailing suppression of cellular link in lever veins and gradual increase of lysozime by 14 days which supposes the use of corresponding immunoprotectors in post-desintoxication period.…”
Get full text
Article -
474
Imaging Features of Rare Hepatic Tumors
Published 2023-09-01“…Hepatic lesions are commonly encountered in radiology practice. …”
Get full text
Article -
475
HLA, gut microbiome and hepatic autoimmunity
Published 2022-08-01Subjects: “…autoimmune hepatitis…”
Get full text
Article -
476
-
477
An Atypical Presentation of Hepatitis E in Pregnancy
Published 2016-06-01Subjects: “…hepatitis e…”
Get full text
Article -
478
Metabolomics in viral hepatitis: advances and review
Published 2023-05-01Subjects: “…viral hepatitis…”
Get full text
Article -
479
Epidemiology of hepatitis A and vaccination policy
Published 2018-02-01Subjects: Get full text
Article -
480
TRAUMATIC INTRAORGANIC HEPATIC AND SPLENIC HEMATOMAS
Published 2015-06-01Subjects: “…hepatic hematoma…”
Get full text
Article